Site içinde arama yapın

Alexa bir ses eklendi Other
2026-11-03 05:56:36 - Translate -

Diabetic Ketoacidosis Treatment Market Set to Hit USD 1.46 Billion by 2036, Featuring Novo Nordisk, Eli Lilly and Sanofi
The global diabetic ketoacidosis treatment market is projected to increase from USD 940.5 million in 2026 to USD 1.46 billion by 2036, registering a compound annual growth rate (CAGR) of 4.5% during the forecast period, according to Fact.MR. The market was valued at USD 900 million in 2025. Demand is supported by rising disease prevalence, improved diagnosis rates and expanding access to...

0 Yorumlar 0 hisse senetleri 36 Views 0 önizleme

Please log in to like, share and comment!
abhi2210 bir ses eklendi Health
2026-09-09 11:56:16 - Translate -

Sarclisa Escena FDA Approval: Sanofi Transforms Multiple Myeloma Treatment Delivery
Sanofi has reached an important milestone in multiple myeloma management with the U.S. approval of Sarclisa Escena, a subcutaneous formulation of isatuximab-irfc administered using the CirCLIQ on-body injector. The U.S. Food and Drug Administration granted approval on July 9, 2026, marking the first anticancer therapy cleared for administration through an on-body injector. This development...

0 Yorumlar 0 hisse senetleri 507 Views 0 önizleme

Please log in to like, share and comment!
Subhayan2 bir ses eklendi Other
2026-06-20 08:53:36 - Translate -

Global Recombinant Human Insulin Market Growing at 5.6% CAGR Through 2034
According to a new report from Intel Market Research, the global Recombinant Human Insulin market was valued at USD 5.8 billion in 2025 and is projected to grow from USD 6.3 billion in 2026 to USD 9.7 billion by 2034, exhibiting a steady CAGR of 5.6% during the forecast period (2026–2034). This growth is driven by the rising prevalence of diabetes globally, advancements in...

0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme

Please log in to like, share and comment!